Yahoo Finance

ProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to ...

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its ...
Yahoo Finance

ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound

Garden City, NY, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics, therapeutics and diagnostics company, today provided an update ...
MarketWatch

ProPhase Labs Inc.

Visit a quote page and your recently viewed tickers will be displayed here.
Nasdaq

ProPhase Labs, Inc. CEO Ted Karkus to Present at Q1 Investor Summit Virtual on March 11th

ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations and ...
Hosted on MSN

ProPhase Labs signs non-binding LOI for proposed reverse merger with ABL

ProPhase Labs (PRPH) and Advanced Biological Laboratories entered into a non-binding Letter of Intent regarding a proposed reverse merger transaction pursuant to which ABL would become the majority ...
Nasdaq

ProPhase Labs, Inc. (PRPH) Tops Q1 Earnings and Revenue Estimates

ProPhase Labs, Inc. (PRPH) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.23 per share a year ago. These ...